Fortier AH - Search Results

1

Recombinant prostate specific antigen inhibits angiogenesis in vitro and in vivo.

Fortier AH, Holaday JW, Liang H, Dey C, Grella DK, Holland-Linn J, Vu H, Plum SM, Nelson BJ. Fortier AH, et al. Prostate. 2003 Aug 1;56(3):212-9. doi: 10.1002/pros.10256. Prostate. 2003. PMID: 12772191

2

Antiangiogenic activity of prostate-specific antigen.

Fortier AH, Nelson BJ, Grella DK, Holaday JW. Fortier AH, et al. J Natl Cancer Inst. 1999 Oct 6;91(19):1635-40. doi: 10.1093/jnci/91.19.1635. J Natl Cancer Inst. 1999. PMID: 10511590

3

Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.

Plum SM, Hanson AD, Volker KM, Vu HA, Sim BK, Fogler WE, Fortier AH. Plum SM, et al. Among authors: fortier ah. Clin Cancer Res. 2003 Oct 1;9(12):4619-26. Clin Cancer Res. 2003. PMID: 14555538

4

Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction.

Plum SM, Vu HA, Mercer B, Fogler WE, Fortier AH. Plum SM, et al. Among authors: fortier ah. Immunopharmacol Immunotoxicol. 2004 Feb;26(1):29-41. doi: 10.1081/iph-120029942. Immunopharmacol Immunotoxicol. 2004. PMID: 15106730

5

Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development.

Plum SM, Holaday JW, Ruiz A, Madsen JW, Fogler WE, Fortier AH. Plum SM, et al. Among authors: fortier ah. Vaccine. 2000 Dec 8;19(9-10):1294-303. doi: 10.1016/s0264-410x(00)00210-3. Vaccine. 2000. PMID: 11137269

6

A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.

Sim BK, O'Reilly MS, Liang H, Fortier AH, He W, Madsen JW, Lapcevich R, Nacy CA. Sim BK, et al. Among authors: fortier ah. Cancer Res. 1997 Apr 1;57(7):1329-34. Cancer Res. 1997. PMID: 9102221

7

Zinc ligand-disrupted recombinant human Endostatin: potent inhibition of tumor growth, safety and pharmacokinetic profile.

Sim BK, Fogler WE, Zhou XH, Liang H, Madsen JW, Luu K, O'Reilly MS, Tomaszewski JE, Fortier AH. Sim BK, et al. Among authors: fortier ah. Angiogenesis. 1999;3(1):41-51. doi: 10.1023/a:1009058931769. Angiogenesis. 1999. PMID: 14517443

8

Liposomal vaccines.

Green S, Fortier A, Dijkstra J, Madsen J, Swartz G, Einck L, Gubish E, Nacy C. Green S, et al. Adv Exp Med Biol. 1995;383:83-92. doi: 10.1007/978-1-4615-1891-4_10. Adv Exp Med Biol. 1995. PMID: 8644517 Review.

9

Rapid generation of specific protective immunity to Francisella tularensis.

Elkins KL, Leiby DA, Winegar RK, Nacy CA, Fortier AH. Elkins KL, et al. Among authors: fortier ah. Infect Immun. 1992 Nov;60(11):4571-7. doi: 10.1128/iai.60.11.4571-4577.1992. Infect Immun. 1992. PMID: 1398969 Free PMC article.

10

In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies.

Leiby DA, Fortier AH, Crawford RM, Schreiber RD, Nacy CA. Leiby DA, et al. Among authors: fortier ah. Infect Immun. 1992 Jan;60(1):84-9. doi: 10.1128/iai.60.1.84-89.1992. Infect Immun. 1992. PMID: 1729199 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page